摘要:
The present invention provides a method for easily and quantitatively evaluating a degree of fatigue of a human being, a kit therefor, and an application thereof. Specifically, by measuring a concentration of amino acid in plasma taken from a subject, the degree of fatigue of the subject in daily life can be easily and quantitatively evaluated. Furthermore, an in vivo anti-fatigue effect of an anti-fatigue substance and that of an anti-fatigue food product can be measured.
摘要:
The present invention provides a method for evaluating the degree of fatigue of a human body. The evaluation method of the present invention is characterized by evaluating the degree of fatigue of a human body by using, as an index, change in waveform of a pulse wave, particularly acceleration pulse wave.
摘要:
A human fatigue assessment device capable of performing highly accurate fatigue assessment is provided. The human fatigue assessment device includes: a physiological signal measuring unit which measures a pulse wave signal of a user; a feature value extracting unit which extracts first feature values each of which is obtained from a systolic posterior component of the pulse wave signal measured by the physiological signal measuring unit; a storage unit in which the first feature values extracted by the feature value extracting unit are stored; and a fatigue determining unit which determines whether or not the user is fatigued, using the first feature values extracted by the feature value extracting unit, in which the fatigue determining unit compares a first feature value among the first feature values extracted by the feature value extracting unit and at least one of the first feature values stored in the storage unit, to determine whether or not the user is fatigued.
摘要:
A human fatigue assessment device capable of performing highly accurate fatigue assessment is provided. The human fatigue assessment device (100) includes: a physiological signal measuring unit (101) which measures a pulse wave signal of a user; a feature value extracting unit (102) which extracts first feature values each of which is obtained from a systolic posterior component of the pulse wave signal measured by the physiological signal measuring unit (101); a storage unit (103) in which the first feature values extracted to by the feature value extracting unit (102) are stored; and a fatigue determining unit (104) which determines whether or not the user is fatigued, using the first feature values extracted by the feature value extracting unit (102), in which the fatigue determining unit (104) compares a first feature value among the first feature values extracted by the feature value extracting unit (102) and at least one of the first feature values stored in the storage unit (103), to determine whether or not the user is fatigued.
摘要:
Ratios of measured values of glucose, citrate, and cis-aconitate in a biological sample obtained from a subject to measured values of glucose, citrate, and cis-aconitate in a biological sample obtained from a healthy subject are calculated, and the glucose ratio, the citrate ratio, and the cis-aconitate ratio are used to evaluate and/or assess fatigue. Similarly, an isocitrate ratio, a succinate ratio, a malate ratio, and a lactate ratio are calculated, and these ratios are used together with the three ratios to evaluate and/or assess fatigue. This makes it possible to objectively and easily diagnose and evaluate fatigue.
摘要:
The present invention provides a labelled acyl-L-carnitine, which is an acyl-L-carnitine, a salt thereof or a derivative thereof, of which carbon group is labelled with a radionuclide or a stable isotope. It is possible to diagnose human diseases falling under acyl-carnitine metabolic syndrome, or human diseases due to structural/functional disorder of the brain by measuring the behavior of the labelled acyl-L-carnitine in various tissues or a biological sample from a subject administered with one or more kinds of the labelled acyl-L-carnitines.
摘要:
An object of the present invention is to provide apparatuses for examining/diagnosing clinical disease of cancer, systemic lupus erythematosus (SLE), or antiphospholipid antibody syndrome. Blood, blood-derived component, urine, sweat, nail, skin, or hair is irradiated with light having a wavelength of 400 to 2,500 nm or a part of the range, of which the reflection light, the transmission light, or the transmission reflection light is then detected to give spectroscopic absorbance data, and afterward a previously prepared analysis model is used to analyze the absorbance over the whole wavelengths or at a specific wavelength for the measurement to allow the achievement of the object.
摘要:
The present invention is a method and an apparatus for examination/diagnosis of lifestyle related disease, wherein the test sample from a human or other animal subject is irradiated with light having a wavelength region of a region of 400 nm-2,500 nm or a part of the region, of which the reflection light, the transmission light, or the transmission reflection light is then detected to give spectroscopic data of absorbance, and afterward a previously prepared analysis model is used to execute an analysis of the absorbance at the whole or specific wavelength used for the measurement.
摘要:
Methods and reagents for transition metal-promoted carbonylation via isocyanate using carbon-isotope labeled carbon monoxide are provided. The resultant carbon-isotope labeled compounds are useful as radiopharmaceuticals, especially for use in Positron Emission Tomography (PET). Associated kits for PET studies are also provided.
摘要:
A labeling compound of the present invention includes a structure represented by formula (1) wherein X1 is 11CH3, CH218F, CF218F, 18F, 76Br or 124I, X2 is CN or NO2, and R is any one of groups represented by or a structure represented by formula (2) wherein X3 is CH3, CH2F, CF3, F, Br or I, and R is defined equally as in the formula (1). This allows realizing a labeling compound for PET, capable of quantifying aromatase with high accuracy.